Changing paradigm in treatment of lung cancer
Changing paradigm in treatment of lung cancer作者机构：Medical OncologyArmy Hospital Research and ReferralNew Delhi 110010India
出 版 物：《Journal of Cancer Metastasis and Treatment》 (癌症转移与治疗（英文版）)
年 卷 期：2016年第2卷第1期
页 面：214-219页
学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
主 题：Non-small cell lung carcinoma epidermal growth factor receptor anaplastic lymphoma kinase
摘 要：Lung cancer is one of the most common and deadliest forms of *** accounts for 13%of all new cancer cases and 19%of cancer-related *** India,lung cancer constitutes 6.9%of all new cancer cases and 9.3%of all cancer *** has also been a dramatic rise worldwide in both the absolute and relative frequencies of lung cancer *** 1953 it became the most common cause of cancer mortality in *** 1985,it became the leading cause of cancer deaths in women,causing almost twice as many deaths as breast *** demographic profile of lung cancer has changed greatly over the years;however,methods for diagnosing,screening,and managing lung cancer patients have *** is due to our growing understanding of the biology of lung *** is now possible to further define lung cancer types beyond small cell lung carcinoma and non-small cell lung ***,new histology-based therapeutic modalities have been developed,and more new lung cancer biomarkers have been ***,more detailed histological characterization of lung cancer samples is warranted in order to determine the best course of treatment for specific *** review article describes how these new molecular technologies are shaping the way lung cancer can be treated in future.
维普期刊数据库